Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis
Anni Laine, Srikar G. Nagelli, Caroline Farrington, et al.
Cancer Research (2021) Vol. 81, Iss. 16, pp. 4319-4331
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Mitotic clustering of pulverized chromosomes from micronuclei
Yu-Fen Lin, Qing Hu, Alice Mazzagatti, et al.
Nature (2023) Vol. 618, Iss. 7967, pp. 1041-1048
Open Access | Times Cited: 49
The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer
Salomé Adam, Silvia Emma Rossi, Nathalie Moatti, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1357-1371
Closed Access | Times Cited: 76
Mitotic tethering enables inheritance of shattered micronuclear chromosomes
Prasad Trivedi, Christopher D. Steele, Franco K.C. Au, et al.
Nature (2023) Vol. 618, Iss. 7967, pp. 1049-1056
Open Access | Times Cited: 40
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A
Karolina Pavic, Nikhil Gupta, Judit Domènech Omella, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer
Lijun Liang, Fuying Yang, Di Wang, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis
Yinyin Shu, Xiaoni Jin, Mintao Ji, et al.
Cancer Research (2024) Vol. 84, Iss. 17, pp. 2836-2855
Closed Access | Times Cited: 8
Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
David B. Neale, Jonathan C. Morris, Nicole M. Verrills, et al.
Pharmacology & Therapeutics (2025), pp. 108834-108834
Closed Access | Times Cited: 1
The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosis
Mara De Marco Zompit, Mònica Torres Esteban, Clémence Mooser, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Emerging insights into serine/threonine-specific phosphoprotein phosphatase function and selectivity
Thomas Kokot, Maja Köhn
Journal of Cell Science (2022) Vol. 135, Iss. 19
Open Access | Times Cited: 22
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers
Sarah C. Moser, Jos Jonkers
Cancer Discovery (2025) Vol. 15, Iss. 3, pp. 461-480
Closed Access
Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression
Nivruthi Sasi, Dilipkumar Preetha, Saranya Iyyappan, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 2, pp. 152340-152340
Closed Access
Phosphorylation-dependent assembly of DNA damage response systems and the central roles of TOPBP1
M.W. Day, Antony W. Oliver, Laurence H. Pearl
DNA repair (2021) Vol. 108, pp. 103232-103232
Open Access | Times Cited: 25
USP13: Multiple Functions and Target Inhibition
Xiaolong Li, Ge Yang, Wenyao Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 18
Oocytes can repair DNA damage during meiosis via a microtubule-dependent recruitment of CIP2A–MDC1–TOPBP1 complex from spindle pole to chromosomes
Jiyeon Leem, Jae‐Sung Kim, Jeong Su Oh
Nucleic Acids Research (2023) Vol. 51, Iss. 10, pp. 4899-4913
Open Access | Times Cited: 10
A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors
Fang‐Tsyr Lin, Kang Liu, Lidija A. Wilhelms Garan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 44
Open Access | Times Cited: 10
CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response
Srikar G. Nagelli, Jukka Westermarck
Trends in cancer (2023) Vol. 10, Iss. 1, pp. 52-64
Open Access | Times Cited: 9
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
Laura V. Bownes, Raoud Marayati, Colin H. Quinn, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1952-1952
Open Access | Times Cited: 13
Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A
Lisa Andriani, Yun-Xiao Ling, Shao‐Ying Yang, et al.
Cancer Letters (2024) Vol. 597, pp. 217008-217008
Closed Access | Times Cited: 2
The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on Hepatoblastoma
Laura V. Bownes, Janet R. Julson, Colin H. Quinn, et al.
Journal of Pediatric Surgery (2023) Vol. 58, Iss. 6, pp. 1145-1154
Open Access | Times Cited: 6
Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema
Brian Soto, Huma Ahmed, M. Pillai, et al.
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 69, Iss. 5, pp. 533-544
Open Access | Times Cited: 5
Recent insights into the causes and consequences of chromosome mis-segregation
Romain Devillers, Alexsandro dos Santos, Quentin Destombes, et al.
Oncogene (2024)
Closed Access | Times Cited: 1
C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies
Raquel L. Arribas, Lucía Viejo, Isaac Bravo, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115245-115245
Open Access | Times Cited: 4
Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities
Umer Ejaz, Zhen Dou, Phil Y. Yao, et al.
Journal of Molecular Cell Biology (2024) Vol. 16, Iss. 4
Open Access | Times Cited: 1
From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer
Beibei Chen, Huihui Hu, Xiaobing Chen
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype
Anna N. Cvrljevic, Umar Butt, Kaisa Huhtinen, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 7, pp. 1236-1245
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top